common.study.topics.clinical

Hantaan Puumala Virus DNA Vaccine

common.study.values.description

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

This is a single-center, randomized, single-blinded study of the Hantaan virus HTNV DNA vaccine alone, Puumala virus PUUV DNA vaccine alone, and mixed Hantaan/Puumala HTNV/PUUV DNA vaccines delivered intramuscularly IM by the needle-free PharmaJet Stratus DSJI device.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Biological - Hantaan Vaccine:

DNA Vaccine 2.0 mg/1 mL phosphate-buffered saline

Biological - Puumala Vaccine

DNA Vaccine 2.0 mg/1 mL phosphate-buffered saline

Biological - Hantaan/Puumala Vaccine

DNA Vaccine 2.0 mg/1 mL phosphate-buffered saline

participant.views.study.view.additional

participant.views.study.view.scientific-title

Hantaan Virus Plasmid DNA (Expressing Gn and Gc Antigens; E. Coli; Althea Technologies, Inc.) Vaccine Hantaan [HTNV-DNA Vaccine] and Puumala Virus DNA (Expressing Gn and Gc Antigens; E. Coli; Althea Technologies, Inc.) Vaccine Puumala [PUUV-DNA Vaccine] Administered Via Stratus Needle-free Injection System (PharmaJet, Inc.)

common.study.values.clinical-trial-id

NCT02776761

participant.views.study.view.id

ZdPKAb